Indication

Amenorrhea secondary to ovarian dysfunction

**Amenorrhea secondary to ovarian dysfunction** refers to the absence of menstrual bleeding caused by intrinsic impairment or failure of the ovaries in female individuals of reproductive age. Read more about Amenorrhea secondary to ovarian dysfunction

15 drugs 14 manufacturers

Advertisement

Drugs that treat it

Common Amenorrhea secondary to ovarian dysfunction therapies.

Showing 10–15 of 15 drugs

PROGESTERONE

PROGESTINS·AMENORRHEA SECONDARY TO OVARIAN DYSFUNCTION·+1
Hikma Pharmaceuticals USA

PROGESTERONE

PROGESTINS·AMENORRHEA SECONDARY TO OVARIAN DYSFUNCTION·+1
EUGIA US LLC

PROGESTERONE

PROGESTINS·AMENORRHEA SECONDARY TO OVARIAN DYSFUNCTION·+1
XIROMED, LLC

PROGESTERONE

PROGESTINS·AMENORRHEA SECONDARY TO OVARIAN DYSFUNCTION·+1
FRESENIUS KABI

PROGESTERONE

PROGESTINS·AMENORRHEA SECONDARY TO OVARIAN DYSFUNCTION·+1
ACCORD HEALTHCA
Filter & compare in the drug finder →Opens the drug finder with Amenorrhea secondary to ovarian dysfunction preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Amenorrhea secondary to ovarian dysfunction.

**Amenorrhea secondary to ovarian dysfunction** refers to the absence of menstrual bleeding caused by intrinsic impairment or failure of the ovaries in female individuals of reproductive age.

This clinical state involves disruption of normal folliculogenesis, anovulation, and deficient or disordered ovarian steroid hormone production—predominantly estradiol and progesterone—which prevents the physiological proliferation and cyclical shedding of the endometrium.

Pathophysiologically, it can manifest with elevated gonadotropins due to the loss of negative feedback in primary ovarian insufficiency, or with variable hormonal imbalances seen in conditions such as polycystic ovary syndrome.

Clinically, affected patients experience secondary amenorrhea (the cessation of menses for three or more months in previously regular cycles, or six months in irregular cycles) and may exhibit associated features of hypoestrogenism, such as vasomotor symptoms and accelerated bone loss.

Personalize your experience

Follow Amenorrhea secondary to ovarian dysfunction and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it